{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:37Z","timestamp":1790649877857,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jhep.2012.06.030","type":"journal-article","created":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T15:45:29Z","timestamp":1341157529000},"page":"946-952","source":"Crossref","is-referenced-by-count":54,"title":["Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study"],"prefix":"10.1016","volume":"57","author":[{"given":"Souvik","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Evon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdus S.","family":"Wahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.06.030_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.510270132","article-title":"Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis","volume":"27","author":"Foster","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.06.030_b0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.06.030_b0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2702.2003.00709.x","article-title":"The experience of fatigue for people living with hepatitis C","volume":"12","author":"Glacken","year":"2003","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.jhep.2012.06.030_b0020","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s10620-006-9708-x","article-title":"Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection","volume":"52","author":"Kallman","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2012.06.030_b0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1665-2681(19)31618-7","article-title":"Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL)","volume":"9","author":"Karaivazoglou","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2893.2010.01292.x","article-title":"Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment","volume":"18","author":"Tillmann","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.06.030_b0035","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.06.030_b0040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00042737-199908000-00004","article-title":"Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection","volume":"11","author":"Goh","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0045","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1023\/A:1021040702370","article-title":"Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale","volume":"47","author":"Hassoun","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2012.06.030_b0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1008960710415","article-title":"Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C","volume":"9","author":"Kleinman","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhep.2012.06.030_b0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1440-1746.2002.02669.x","article-title":"Fatigue and psychological disorders in chronic hepatitis C","volume":"17","author":"McDonald","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291701004615","article-title":"Fatigue, depression and chronic hepatitis C infection","volume":"32","author":"Wessely","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0065","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0070","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0075","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0080","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0085","first-page":"5","article-title":"Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study","volume":"73","author":"Van Vlierberghe","year":"2010","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jhep.2012.06.030_b0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2003.12.014","article-title":"The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C","volume":"40","author":"Hassanein","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","article-title":"Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis","volume":"46","author":"Bonkovsky","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0168-8278(00)00026-X","article-title":"The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity","volume":"34","author":"McHutchison","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.06.030_b0110","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/597384","article-title":"Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection","volume":"199","author":"Hoofnagle","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2012.06.030_b0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2008.02.035","article-title":"Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection","volume":"6","author":"Howell","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0120","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2008.08.006","article-title":"Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C","volume":"6","author":"Terrault","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jhep.2012.06.030_b0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006199-198909000-00006","article-title":"Visual analogue scales: measurement of subjective phenomena","volume":"38","author":"Gift","year":"1989","journal-title":"Nurs Res"},{"key":"10.1016\/j.jhep.2012.06.030_b0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-277X.2008.00882.x","article-title":"The impact of combination therapy with peginterferon alpha-2a and ribavirin on the energy intake and body weight of adult hepatitis C patients","volume":"21","author":"Hamer","year":"2008","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.jhep.2012.06.030_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2377-6-27","article-title":"A rapid screening tool for fatigue impact in multiple sclerosis","volume":"6","author":"Kos","year":"2006","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jhep.2012.06.030_b0145","doi-asserted-by":"crossref","first-page":"e30123","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sjogren\u2019s syndrome\u2013a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2012.06.030_b0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/030097400446698","article-title":"Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists\u2013preliminary results","volume":"113","author":"Spath","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jhep.2012.06.030_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-4-13","article-title":"Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]","volume":"4","author":"ter Borg","year":"2004","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2012.06.030_b0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1008960710415","article-title":"Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C","volume":"9","author":"Kleinman","year":"2000","journal-title":"Quality of life research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation"},{"key":"10.1016\/j.jhep.2012.06.030_b0165","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/ajg.2009.528","article-title":"Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study","volume":"104","author":"Evon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.06.030_b0170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpainsymman.2005.08.016","article-title":"Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection","volume":"31","author":"Lang","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jhep.2012.06.030_b0180","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-2036.2011.04842.x","article-title":"PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis","volume":"34","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2012.06.030_b0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/jir.2009.0059","article-title":"N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C","volume":"30","author":"Antonelli","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2012.06.030_b0190","first-page":"1","article-title":"Molecular signatures of peripheral blood mononuclear cells during chronic interferon-alpha treatment: relationship with depression and fatigue","author":"Felger","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.jhep.2012.06.030_b0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2893.2000.00249.x","article-title":"Serum cytokine values and fatigue in chronic hepatitis C infection","volume":"7","author":"Gershon","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2012.06.030_b0200","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbi.2007.12.009","article-title":"IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C","volume":"22","author":"Majer","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jhep.2012.06.030_b0205","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bbi.2010.04.012","article-title":"A formal analysis of cytokine networks in chronic fatigue syndrome","volume":"24","author":"Broderick","year":"2010","journal-title":"Brain Behav Immun"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812005235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812005235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T08:42:59Z","timestamp":1561884179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812005235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0168827812005235"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.06.030","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}